rhodomycinone has been researched along with Carcinoma, Small Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demant, EJ; Friche, E; Hansen, HH; Jensen, PB; Kjeldsen, E; Sehested, M; Sørensen, BS | 1 |
1 other study(ies) available for rhodomycinone and Carcinoma, Small Cell
Article | Year |
---|---|
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carcinoma, Small Cell; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Lung Neoplasms; Mice; Naphthacenes; Stimulation, Chemical; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |